药明合联
港股通 官网
( 02268.hk)
市盈率41.40市净率5.71股息率0%上市时间2023-11-17股价54.10港币涨跌幅-3.31%成交金额3.14亿港币换手率0.45%市值681.99亿港币H股市值681.99亿港币总股本12.61亿H股本12.61亿每手股数500上市至今年化投资收益率30.26%港股通持仓占H股比例12.19% (87.08亿港币2026-05-12) 累计做空占H股比例2.51% (18.62亿港币2026-04-30)
所属三级行业生物技术 (恒生) 市盈率103.94市净率4.24股息率0.38%恒生:医疗保健业药品及生物科技生物技术
所属指数指数纳入纳出
备注 (3): 双击编辑备注
发表讨论

药明合联(02268) - 历史董事名单

# 姓名职衔职位委任日期辞任日期
1GRAWUNDER UlfIndependent Non Executive Director2023-11-17--
2HEN Stewart JohnIndependent Non Executive Director2023-11-17--
3周浩Independent Non Executive Director - A/F2023-11-17--
4施明Non Executive Director2023-06-01--
5席曉捷Executive Director2023-06-01--
6張靖偉Executive Director2023-06-01--
7陳智勝Non Executive DirectorChairman2020-12-01--
8李錦才Executive DirectorCEO2020-12-01--
9周偉昌Non Executive Director2020-12-01--